Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $969.72M.
ENTERPRISE VALUE (EV)
$969.72M
Janux Therapeutics, Inc.
Market Cap
$1.02B
Enterprise Value (EV)
$969.72M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Janux Therapeutics, Inc. (JANX) | $1.02B | $969.72M |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | $992.75M |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | $1.93B |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | $2.85B |
| Immatics N.V. (IMTX)vs › | $1.01B | $761.44M |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.00B | $927.35M |
| Vor Biopharma Inc. (VOR)vs › | $993.23M | $888.25M |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | $1.31B |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $991.24M | $840.83M |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $980.66M | $702.76M |
Market Cap
$1.02B
Total Debt
$2.39M
Cash
$52.33M
Enterprise Value
$969.72M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
